BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8702914)

  • 1. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5.
    Nishitoh H; Ichijo H; Kimura M; Matsumoto T; Makishima F; Yamaguchi A; Yamashita H; Enomoto S; Miyazono K
    J Biol Chem; 1996 Aug; 271(35):21345-52. PubMed ID: 8702914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of receptors for bone morphogenetic proteins].
    Nishitoh H
    Kokubyo Gakkai Zasshi; 1997 Mar; 64(1):24-37. PubMed ID: 9125848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of BMP receptor synthesis by antisense oligonucleotides attenuates OP-1 action in primary cultures of fetal rat calvaria cells.
    Yeh LC; Betchel KP; Lee JC
    J Bone Miner Res; 1998 Dec; 13(12):1870-9. PubMed ID: 9844105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation.
    Ebisawa T; Tada K; Kitajima I; Tojo K; Sampath TK; Kawabata M; Miyazono K; Imamura T
    J Cell Sci; 1999 Oct; 112 ( Pt 20)():3519-27. PubMed ID: 10504300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
    Yamashita H; ten Dijke P; Huylebroeck D; Sampath TK; Andries M; Smith JC; Heldin CH; Miyazono K
    J Cell Biol; 1995 Jul; 130(1):217-26. PubMed ID: 7790373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single residue of GDF-5 defines binding specificity to BMP receptor IB.
    Nickel J; Kotzsch A; Sebald W; Mueller TD
    J Mol Biol; 2005 Jun; 349(5):933-47. PubMed ID: 15890363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic proteins and growth and differentiation factors in the human cornea.
    You L; Kruse FE; Pohl J; Völcker HE
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):296-311. PubMed ID: 9950587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs.
    Liu F; Ventura F; Doody J; Massagué J
    Mol Cell Biol; 1995 Jul; 15(7):3479-86. PubMed ID: 7791754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.
    Namiki M; Akiyama S; Katagiri T; Suzuki A; Ueno N; Yamaji N; Rosen V; Wozney JM; Suda T
    J Biol Chem; 1997 Aug; 272(35):22046-52. PubMed ID: 9268344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis.
    Erlacher L; McCartney J; Piek E; ten Dijke P; Yanagishita M; Oppermann H; Luyten FP
    J Bone Miner Res; 1998 Mar; 13(3):383-92. PubMed ID: 9525338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of serine/threonine kinase receptors including the bone morphogenetic factor type II receptor in the developing and adult rat brain.
    Söderström S; Bengtsson H; Ebendal T
    Cell Tissue Res; 1996 Nov; 286(2):269-79. PubMed ID: 8854897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.
    Nickel J; Dreyer MK; Kirsch T; Sebald W
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S7-14. PubMed ID: 11263668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts.
    Akiyama S; Katagiri T; Namiki M; Yamaji N; Yamamoto N; Miyama K; Shibuya H; Ueno N; Wozney JM; Suda T
    Exp Cell Res; 1997 Sep; 235(2):362-9. PubMed ID: 9299160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of osteogenic protein-1 (OP-1, BMP-7) on gene expression in cultured medial collateral ligament cells.
    Tsai AD; Yeh LC; Lee JC
    J Cell Biochem; 2003 Nov; 90(4):777-91. PubMed ID: 14587033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament.
    Yonemori K; Imamura T; Ishidou Y; Okano T; Matsunaga S; Yoshida H; Kato M; Sampath TK; Miyazono K; ten Dijke P; Sakou T
    Am J Pathol; 1997 Apr; 150(4):1335-47. PubMed ID: 9094990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of a human type II receptor for bone morphogenetic proteins.
    Rosenzweig BL; Imamura T; Okadome T; Cox GN; Yamashita H; ten Dijke P; Heldin CH; Miyazono K
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7632-6. PubMed ID: 7644468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of bone morphogenetic protein receptors during chondrocyte maturation.
    Volk SW; D'Angelo M; Diefenderfer D; Leboy PS
    J Bone Miner Res; 2000 Aug; 15(8):1630-9. PubMed ID: 10934663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation.
    Ishidou Y; Kitajima I; Obama H; Maruyama I; Murata F; Imamura T; Yamada N; ten Dijke P; Miyazono K; Sakou T
    J Bone Miner Res; 1995 Nov; 10(11):1651-9. PubMed ID: 8592941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.